![Jennifer Russo Wortman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jennifer Russo Wortman
No open positions remaining
Profile
Jennifer Russo Wortman formerly worked at The Broad Institute, Inc., as Director-Microbial Informatics from 2011 to 2015, Institute For Genome Sciences, as Associate Director-Bioinformatics, and Seres Therapeutics, Inc., as VP-Clinical Discovery & Research Technology from 2019 to 2023.
Ms. Wortman received her graduate degree from The University of North Carolina at Chapel Hill.
Former positions of Jennifer Russo Wortman
| Companies | Position | End |
|---|---|---|
| SERES THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 30/11/2023 |
Institute For Genome Sciences
 Institute For Genome Sciences BiotechnologyHealth Technology Provides research and development services for microbiologist | Corporate Officer/Principal | - |
Training of Jennifer Russo Wortman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
16
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
The University of North Carolina at Chapel Hill
 The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seres Therapeutics, Inc.
 Seres Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for diseases related to the human microbiome | Health Technology |
Institute For Genome Sciences
Institute For Genome Sciences BiotechnologyHealth Technology Provides research and development services for microbiologist | Health Technology |
- Stock Market
- Insiders
- Jennifer Russo Wortman
